Ads
related to: alternative to diltiazem for afib risk loss reduction in pregnancy- 262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464
- Should I See a Heart Doc
Talk to your doc about your heart
and learn what to ask
- Find a Doctor
Meet with our experts to diagnose
your symptoms and receive treatment
- Patient Testimonials
Hear from our patients
about their Ohio State experience
- Prepare For Your Visit
What to bring to your visit
plus heart & vascular resources
- Should I See a Heart Doc
Search results
Results from the WOW.Com Content Network
In a later atrial fibrillation trial, ATHENA, with 4628 subjects, dronedarone was significantly more effective than placebo in reducing the composite endpoint of first hospitalization due to cardiovascular events or death. [17] There was a significant reduction in the rate of cardiovascular death, but not in the rate of death from any cause. [5]
Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of cardiac dysrhythmias. [4] This includes ventricular tachycardia, ventricular fibrillation, and wide complex tachycardia, atrial fibrillation, and paroxysmal supraventricular tachycardia. [4]
In 1972, when it was one of the only alternatives to quinidine, it was praised for being more potent and somewhat less toxic. [6] However, a 2012 review of antiarrhythmic drugs noted that disopyramide is among the most toxic agents, with a high burden of side effects and increased mortality (compared to placebo) when used to treat atrial ...
In 1912, Karel Frederik Wenckebach saw a man with atrial fibrillation. He was a Dutch merchant, used to good order in his affairs. He was a Dutch merchant, used to good order in his affairs. He would like to have good order in his heart business, also, and asked, "why there were heart specialists if they could not abolish this very disagreeable ...
Dabigatran is used to prevent strokes in those with atrial fibrillation not caused by heart valve issues, as well as deep vein thrombosis and pulmonary embolism in persons who have been treated for 5–10 days with parenteral anticoagulant (usually low molecular weight heparin), and to prevent deep vein thrombosis and pulmonary embolism in some circumstances.
Apixaban is recommended by the National Institute for Health and Clinical Excellence for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation and at least one of the following risk factors: prior stroke or transient ischemic attack, age 75 years or older, diabetes, or symptomatic heart failure.
Ads
related to: alternative to diltiazem for afib risk loss reduction in pregnancy- 262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464
